Fall Clinical 2025 News: Castle’s DecisionDx-Melanoma Stratifies Risk Across Histological Subtypes

October 24, 2025

Wearable Patch May Help ID Early Skin Cancer via Bioimpedance

October 23, 2025

ESMO 2025 News: Can Adjuvant Pembrolizumab Stave Off MCC Spread?

October 20, 2025

New Drop From EltaMD: UV Daily Hydration+

October 17, 2025

U.S. FDA Approves Cemiplimab to Treat cSCC With High Risk of Recurrence After Surgery and Radiation

October 8, 2025

Topical PI3K/mTOR Inhibitor Shows Promise in Proof-Of-Concept AK Study

October 6, 2025

Can Having More Tattoos Lower Your Risk of Melanoma?

September 24, 2025

U.S. FDA Clears IND for Rubedo’s RLS-1496 for AK; Dr. Emma Guttman-Yassky Joins Company’s Clinical Advisory Board

September 23, 2025

Study Validates Nicotinamide’s Role in Skin Cancer Chemoprevention

September 18, 2025

Milestone Alert: Last Patient Completes Phase 3 Study of Biofrontera’s Ameluz PDT for AKs on the Extremities, Neck, and Trunk

September 17, 2025

Man vs. Machine: Exploring AI’s Role in Assessing the Aggressiveness of cSCC

September 12, 2025

Supportive Oncodermatology News: Hoth Therapeutics Submits CTA to EMA for Phase 2 Study of HT-001 in Cancer Patients With EGFRi-induced Skin Toxicities

September 11, 2025